MedPath

Trapeziectomy: Internal Brace vs. Ligament Reconstruction (Prospective)

Not Applicable
Recruiting
Conditions
Basilar Thumb Arthritis
Registration Number
NCT05753891
Lead Sponsor
Henry Ford Health System
Brief Summary

This study seeks to compare two methods of trapeziectomy for basilar thumb arthritis. The first is trapeziectomy with ligament reconstruction and tendon interposition, which means removing the trapezium bone and filling the void with a tendon graft. This is the most commonly used procedure and the control group. The experimental group is trapeziectomy with suture tape suspension of the 1st metacarpal to the 2nd metacarpal. This is using a device called the InternalBrace, produced by Arthrex.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Patients of Henry Ford Orthopedic Service Line
  • Symptomatic basilar thumb arthritis refractory to conservative management
Exclusion Criteria
  • Significant medical comorbidity precluding safe surgery, as determined by the operating surgeon. This may include cardiac disease, renal disease, liver disease, pulmonary disease, or heavy substance abuse.
  • Requirement for additional procedures at the 1st carpometacarpal joint, including trapezoid excision-whole or partial-or metacarpal osteotomy. Of note other existing conditions requiring intervention on a separate surgical site such as concomitant carpal tunnel syndrome or trigger fingers will NOT be used as exclusion criteria.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pinch Strength6 months post procedure

Pinch Strength measurements

Secondary Outcome Measures
NameTimeMethod
PROMIS-UE6 months post procedure

Patient-Reported outcomes measurement information system (PROMIS) Upper Extremity (UE) item bank to record upper extremity function.

Trial Locations

Locations (1)

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

Henry Ford Health System
🇺🇸Detroit, Michigan, United States
Charles S Day, M.D., M.B.A.
Contact
313-916-5846
cday9@hfhs.org
Elizabeth A Washnock-Schmid, B.S.
Contact
8103474714
gn3092@wayne.edu
Charles S Day, MD, MBA
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.